Sorrento Therapeutics and researchers at Israel's Ben-Gurion University of the Negev are partnering to develop anti-hepatitis C antibodies.
The U.K. government has launched a major initiative to map the genetic causes of cancer as well as rare and infectious diseases.
A cancer-fighting compound being tested in clinical trials for some types of leukemia could also have potential for treating the most common form of breast cancer, a team of Australian researchers found.
At a time when most of the biopharma industry has focused its preclinical research on screening synthetic compounds for their drug potential, Biosortia Pharmaceuticals is going back to nature to find promising compounds at the early stage of discovery. Read more >>
Researchers at the University of Kentucky Sanders-Brown Center on Aging may have uncovered the mechanism of action behind a kind of experimental Alzheimer's therapy called intravenous immunoglobulin, also known as Gammagard™ IVIg.
An experimental vaccine to combat the virulent, newly emerging H7N9 avian flu vaccine caused cellular immune responses that could not only reduce the severity of the infection in a person who catches the virus but also limit the spread of the deadly flu strain in a pandemic setting.
Researchers may be on their way to finding safer drugs for treating arthritis that don't cause potentially harmful cardiovascular side effects like some past and current medications.
For most people in the Western world, the mention of tuberculosis is likely to conjure up images of the Victorians. In richer countries, tuberculosis is, for the most part, a thing of the past.
An FDA-approved asthma medication may be able to slow brain deterioration and cognitive decline in Down syndrome patients, according to a new study.
The nonprofit, Silicon Valley-based Myelin Repair Foundation has licensed its new mouse model for demyelinating diseases like multiple sclerosis to Biogen Idec ($BIIB) for the company's drug discovery programs.
The U.K. could be lagging behind in regenerative medicine and missing out on opportunities to translate basic science to commercially viable treatments, a new report by Parliament's House of Lords found.
Researchers at the University of North Carolina at Chapel Hill have found that genetically engineered mouse models are able to predict how humans will respond to different chemotherapy drug combinations used to fight breast cancer.
Texas A&M University has launched a new cross-disciplinary genomics research initiative to study how animal, human, and ecosystem health are connected, with the aim of a creating world-class genomics program.
The National Institutes of Health announced Wednesday its plans to significantly reduce the number of chimpanzees it uses in NIH-funded biomedical research.
Researchers have found an RNA molecule that interferes with the production of lipoproteins, which could provide the basis for new therapies to treat high cholesterol.
A genetic mechanism uncovered by neurology researchers could explain why some patients with multiple sclerosis progress more rapidly to a severe stage of the disease while other patients progress more slowly.
Researchers at Duke Medicine have found a way to prevent epilepsy in mice that have already experienced a long period of seizures--a feat that could help scientists develop new drugs to treat the serious neurological disorder.
Researchers at the Moffitt Cancer Center in Tampa, FL, are tapping into nature to find the next potential treatment for brain tumors.
In what could be a significant advance toward better treatments for pancreatic cancer--a deadly type of cancer with an overall 5-year survival rate of about 6%-- scientists have developed what they say is the first-of-its-kind human-cell model of the disease.
Researchers from the Medical College of Wisconsin have found that an antioxidant called diapocynin, a synthetic molecule derived from the naturally occurring compound apocynin, was effective at preventing Parkinson's-like symptoms in mice.